RS
Rinki Singh
About Rinki Singh
Data last updated:
Rinki Singh is a Director at Medimount Pharmaceuticals Private Limited (since 2019) and Nominee at Medimount Lifesciences (Opc) Private Limited (since 2026). The companies operate in Chemicals. The largest current company by reported revenue is Medimount Pharmaceuticals Private Limited at ₹15 Lakh (FY 2023).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Medimount Pharmaceuticals Private Limited U24230MH2019PTC322145 | Director | 05 Mar 2019 | 2019 | ₹15 Lakh (FY 2023) | Active |
| Medimount Lifesciences (Opc) Private Limited U47721MR2026OPC478019 | Nominee | 02 Jul 2026 | 2026 | Active |
Board colleagues of Rinki Singh
| Name | DIN | Company | Designation |
|---|---|---|---|
| Kumari Sangita Singh | 08380628 | Medimount Pharmaceuticals Private Limited | Director |
| Vijay Kumar Singh | 11801385 | Medimount Lifesciences (Opc) Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Rinki Singh
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rinki Singh
Rinki Singh currently holds 2 directorships: Medimount Pharmaceuticals Private Limited (Director, since 05 Mar 2019, revenue ₹15 Lakh (FY 2023)); Medimount Lifesciences (Opc) Private Limited (Nominee, since 02 Jul 2026).
Rinki Singh was first appointed on 05 Mar 2019 as Director at Medimount Pharmaceuticals Private Limited. The most recent appointment on record is 02 Jul 2026 at Medimount Lifesciences (Opc) Private Limited.
The current boards of Rinki Singh's companies include Kumari Sangita Singh (Medimount Pharmaceuticals Private Limited), Vijay Kumar Singh (Medimount Lifesciences (Opc) Private Limited).